Case series analysis of adverse reactions to vaccines: A comparative evaluation

American Journal of Epidemiology

Volumn 143, Issue 11, 1996, Pages 1165-1173

  Farrington, C P ^a   Nash, J ^b   Miller, E ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b WILLIAM HARVEY HOSPITAL   (United Kingdom)

Author keywords

case control studies; cohort studies; epidemiologic methods; statistics; vaccination

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; FEBRILE CONVULSION; HUMAN; MAJOR CLINICAL STUDY; STATISTICAL ANALYSIS; THEORY; UNITED KINGDOM; VACCINATION;

EID: 0029934226     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008695     Document Type: Article

References (18)

1. Fine PE, Chen RT. Confounding in studies of adverse reactions to vaccines. Am J Epidemiol 1992;136:121-35.
2. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol 1989;129:837-49.
3. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 1995;51:228-35.
4. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991;133:144-53.
5. Feldmann U. Epidemiologic assessment of risks of adverse reactions associated with intermittent exposure. Biometrics 1993;49:419-28.
6. Marshall RJ, Jackson RT. Analysis of case-crossover designs. Stat Med 1993;12:2333-41.
7. Farrington P, Pugh S, Colville A, et al. A new method for active surveillance of adverse events from diphtheria/tetanus/ pertussis and measles/mumps/rubella vaccines. Lancet 1995; 345:567-9.
8. Griffin MR, Ray WA, Mortimer EA, et al. Risk of seizures and encephalopathy after immunization with the diphtheriatetanus-pertussis vaccine. JAMA 1990;263:1641-5.
9. Griffin MR, Ray WA, Livengood JR, et al. Risk of sudden infant death syndrome after immunization with the diphtheriatetanus-pertussis vaccine. N Engl J Med 1988;319:618-23.
10. Griffin MR, Ray WA, Mortimer EA, et al. Risk of seizures after measles-mumps-rubella immunization. Pediatrics 1991; 88:881-5.
11. Griffin MR, Taylor JA, Daugherty JR, et al. No increased risk for invasive bacterial infection found following diphtheriatetanus-pertussis immunization. Pediatrics 1992;89:640-2.
12. Alderslade R, Bellman M, Rawson NS, et al. The National Childhood Encephalopathy Study. In: Whooping cough: reports from the Committee on Safety of Medicines and the Joint Committee on Vaccination and Immunisation. London, England: Her Majesty's Stationery Office, 1981:79-169.
13. Walker AM, Jick H, Perera DR, et al. Diphtheria-tetanuspertussis immunization and sudden infant death syndrome. Am J Public Health 1987;77:945-51.
14. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986;73: 1-11.
15. Chen RT, Rastogi SC, Mullen JR, et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine 1994;12:542-50.
16. Miller E, Goldacre M, Pugh S, et al. Risk of aseptic meningitis after measles, mumps and rubella vaccine in UK children. Lancet 1993;341:979-82.
17. Wassilak SG, Glasser JW, Chen RT, et al. Utility of largelinked databases in vaccine safety, particularly in distinguishing independent and synergistic effects. The Vaccine Safety Datalink Investigators. Ann N Y Acad Sci 1995;754:377-82.
18. Nash JQ, Chandrakumar M, Farrington CP, et al. Feasibility study for identifying adverse events attributable to vaccination by record linkage. Epidemiol Infect 1995;114:475-80.